share_log

Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug

Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug

Ainos和Tah-An签署谅解备忘录探讨VELDONA动物研究新药的制造
Benzinga Real-time News ·  2023/01/23 07:12

Ainos advances commercialization of its VELDONA low-dose interferon treatment through strategic partnerships

Ainos通过战略合作伙伴关系推进其VELDONA低剂量干扰素疗法的商业化

Ainos intends to begin clinical trials into VELDONA's potential veterinary applications in the first quarter of 2023

Ainos打算在2023年第一季度开始对VELDONA的潜在兽医应用进行临床试验

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发